Cargando…

Efficacy and safety of fluticasone furoate nasal spray in adult and adolescent subjects with uncomplicated acute rhinosinusitis

Detalles Bibliográficos
Autores principales:	Keith, Paul, Dymek, Andrzej, Pfaar, Oliver, Fokkens, Wytske, Topors, Nazli, Wu, Wei, Yun Kirby, Suyong, Lee, Laurie A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242205/ http://dx.doi.org/10.1186/1710-1492-7-S2-A41

Ejemplares similares

Fluticasone furoate nasal spray in the treatment of allergic rhinitis
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2008)

Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis
por: Doulaptsi, Maria, et al.
Publicado: (2021)

A patient preference study that evaluated fluticasone furoate and mometasone furoate nasal sprays for allergic rhinitis
por: Yanez, Anahi, et al.
Publicado: (2016)

Efficacy and Safety of Once Daily Fluticasone Furoate Nasal Spray for Treatment of Irritant (Non-allergic) Rhinitis
por: Tantilipikorn, Pongsakorn, et al.
Publicado: (2010)

Fluticasone furoate nasal spray: Profile of an enhanced-affinity corticosteroid in treatment of seasonal allergic rhinitis
por: Anolik, Robert
Publicado: (2010)

Efficacy of fluticasone furoate nasal spray and levocetirizine in patients with Japanese cedar pollinosis subjected to an artificial exposure chamber
por: Hashiguchi, Kazuhiro, et al.
Publicado: (2013)

Chronic rhinosinusitis with nasal polyps in the elderly
por: Cornet, Marjolein, et al.
Publicado: (2013)

Fluticasone furoate/fluticasone propionate – different drugs with different properties
por: Biggadike, Keith
Publicado: (2011)

Precision Medicine in Chronic Rhinosinusitis with Nasal Polyps
por: Avdeeva, Klementina, et al.
Publicado: (2018)

Suppression of Cytokine Release by Fluticasone Furoate vs. Mometasone Furoate in Human Nasal Tissue Ex-Vivo
por: Zhang, Nan, et al.
Publicado: (2014)

Efficacy of mometasone furoate and fluticasone furoate on persistent allergic rhinoconjunctivitis
por: Aneeza, W. Hamizan, et al.
Publicado: (2013)

Efficacy and Safety of Fluticasone Furoate and Oxymetazoline Nasal Spray: A Novel First Fixed Dose Combination for the Management of Allergic Rhinitis with Nasal Congestion
por: Kumar, R S, et al.
Publicado: (2022)

Symptoms of chronic rhinosinusitis with and without nasal polyps
por: Dietz de Loos, Dirk, et al.
Publicado: (2013)

Mometasone furoate nasal spray: a systematic review
por: Passali, Desiderio, et al.
Publicado: (2016)

Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluated
por: Kariyawasam, Harsha H, et al.
Publicado: (2010)

Pharmacodynamics and Pharmacokinetics of Fluticasone Furoate/Vilanterol in Healthy Chinese Subjects
por: Chen, Xia, et al.
Publicado: (2015)

Liposomal Nasal Spray versus Guideline-Recommended Steroid Nasal Spray in Patients with Chronic Rhinosinusitis: A Comparison of Tolerability and Quality of Life
por: Eitenmüller, Anna, et al.
Publicado: (2014)

Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19
por: Boulware, David R., et al.
Publicado: (2023)

Long-term results of functional endoscopic sinus surgery in children with chronic rhinosinusitis with nasal polyps
por: Cornet, Marjolein, et al.
Publicado: (2013)

Molecular Mechanisms of Nasal Epithelium in Rhinitis and Rhinosinusitis
por: Toppila-Salmi, Sanna, et al.
Publicado: (2014)

Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk
por: Covelli, Henry, et al.
Publicado: (2015)

The Relationship Between Fluticasone Furoate Systemic Exposure and Cortisol Suppression
por: Allen, Ann
Publicado: (2013)

Pharmacokinetics and pharmacodynamics of intravenous and inhaled fluticasone furoate in healthy Caucasian and East Asian subjects
por: Allen, Ann, et al.
Publicado: (2014)

Population Pharmacokinetics of Inhaled Fluticasone Furoate and Vilanterol in Subjects with Chronic Obstructive Pulmonary Disease
por: Siederer, Sarah, et al.
Publicado: (2015)

Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma
por: O’Byrne, Paul M., et al.
Publicado: (2014)

Modulation of allergen-induced bronchoconstriction by fluticasone furoate and vilanterol alone or in combination
por: Oliver, A, et al.
Publicado: (2013)

Intranasal fluticasone furoate in pediatric allergic rhinitis: randomized controlled study
por: Zhang, Yamei, et al.
Publicado: (2020)

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial
por: Day, Nicola C., et al.
Publicado: (2020)

The interest of fluticasone nasal spray in COVID-19 related anosmia is still not demonstrated
por: Lechien, Jerome R., et al.
Publicado: (2021)

Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia – An Observational Real-World Clinical Study
por: Fifer, Simon, et al.
Publicado: (2023)

Pharmacokinetics of fluticasone furoate, umeclidinium, and vilanterol as a triple therapy in healthy volunteers
por: Brealey, Noushin, et al.
Publicado: (2015)

Pharmacokinetics of fluticasone furoate, umeclidinium, and vilanterol as a triple therapy in healthy volunteers
Publicado: (2016)

Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma
por: O’Byrne, Paul M., et al.
Publicado: (2016)

Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study
por: Bremner, Peter R., et al.
Publicado: (2018)

Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey
por: Fromer, Leonard M, et al.
Publicado: (2008)

A repeat-dose thorough QT study of inhaled fluticasone furoate/vilanterol combination in healthy subjects
por: Kempsford, Rodger, et al.
Publicado: (2014)

Development of simple and fast UV-method for the quantitative determination of mometasone furoate in a large number of metered doses of an aqueous nasal spray of mometasone furoate
por: Levin, Mykhaylo, et al.
Publicado: (2019)

Fluticasone Furoate, a Novel Inhaled Corticosteroid, Demonstrates Prolonged Lung Absorption Kinetics in Man Compared with Inhaled Fluticasone Propionate
por: Allen, Ann, et al.
Publicado: (2012)

Relieving nasal congestion in children with seasonal and perennial allergic rhinitis: efficacy and safety studies of mometasone furoate nasal spray
por: Meltzer, Eli O, et al.
Publicado: (2013)

Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate
por: Valotis, Anagnostis, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_hh4jb4vm46iid1hjcnu95u02ah